112 related articles for article (PubMed ID: 2012403)
21. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M
Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
[TBL] [Abstract][Full Text] [Related]
22. [A case of carcinoma corporis by intra-arterial hypertension chemotherapy].
Yoshino N; Iwanari O; Ryukou K; Moriyama M; Kitao M; Fujita Y; Yashi K
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3003-6. PubMed ID: 2782904
[TBL] [Abstract][Full Text] [Related]
23. [A case of successful management of nonresectable pancreas cancer with liver metastasis by intra-arterial infusion chemotherapy with angiotensin-II and administration of tegafur/uracil].
Ishikawa T; Sato S; Matsuzawa J; Mita Y; Matsui S; Tashiro K; Tashiro S; Matsuki H
Gan To Kagaku Ryoho; 2001 Apr; 28(4):521-5. PubMed ID: 11329788
[TBL] [Abstract][Full Text] [Related]
24. [Combined chemotherapy with low-dose cisplatin, tegafur and uracil in a case with neck recurrence of laryngeal cancer].
Nishino H; Tanaka H; Ishikawa K; Kanazawa T; Miyata M; Kitamura K
Gan To Kagaku Ryoho; 1998 Oct; 25(12):1973-5. PubMed ID: 9797823
[TBL] [Abstract][Full Text] [Related]
25. [Complete remission of liver metastasis from rectal cancer following continuous oral administration of tegafur-uracil after intrahepatic arterial single injection of CDDP and 5-FU].
Oguro A; Nanri M; Miyamoto Y; Ikoma H; Chimori Y; Yamane E; Nishioka B
Gan To Kagaku Ryoho; 1998 Sep; 25(11):1767-9. PubMed ID: 9757204
[TBL] [Abstract][Full Text] [Related]
26. [The hypertensive effect induced with angiotensin II and the physiological and pharmacokinetic aspects of two-route chemotherapy using CDDP and STS].
Takizawa K; Harada M; Fujimaru J; Shima Y; Yokoo I; Ozaki I; Sato M; Iguchi T; Takeda Y
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1569-74. PubMed ID: 2389950
[TBL] [Abstract][Full Text] [Related]
27. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
[TBL] [Abstract][Full Text] [Related]
28. [Combination therapy of a novel oral fluorouracil derivative TS-1 with low-dose cisplatin for recurrent and very advanced gastric cancer].
Nakata B; Hirakawa K
Gan To Kagaku Ryoho; 2004 Nov; 31(12):1962-8. PubMed ID: 15570921
[TBL] [Abstract][Full Text] [Related]
29. A phase II study of oral UFT and leucovorin concurrently with pelvic irradiation as neoadjuvant chemoradiation for rectal cancer.
Kundel Y; Brenner B; Symon Z; Oberman B; Sadezki S; Koller M; Catane R; Pfeffer R
Anticancer Res; 2007; 27(4C):2877-80. PubMed ID: 17695464
[TBL] [Abstract][Full Text] [Related]
30. [A case of recurrent endometrial cancer (clear cell adenocarcinoma) remarkably responsive to combination chemotherapy containing cisplatin].
Kitayama S; Iwahashi M; Iwahashi M; Yamoto M; Nakano R
Gan To Kagaku Ryoho; 1989 May; 16(5):2099-101. PubMed ID: 2730095
[TBL] [Abstract][Full Text] [Related]
31. [Local chemo-hyperthermotherapy of recurrent rectal cancer].
Fukuda I; Kameyama M; Iwanaga T; Doi O; Koyama H; Imaoka S; Furukawa H; Kodama K; Kabuto T; Ishikawa O
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1337-41. PubMed ID: 3382204
[TBL] [Abstract][Full Text] [Related]
32. [Combination chemotherapy of UFT with adriamycin (ADM) and cisplatin (CDDP) for advanced gastrointestinal cancer].
Koda K; Nakazawa O; Morita K; Kure T; Terada S; Matsunaga T; Tsuji Y; Miyazaki E; Nakajima K; Morii K
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1893-900. PubMed ID: 2118336
[TBL] [Abstract][Full Text] [Related]
33. [Treatment for peritoneal dissemination of gastric cancer by intraperitoneal administration of CDDP through Infuse-a-Port].
Yoshiyuki T; Onda M; Tokunaga A; Teramoto T; Oguri T; Fujita I; Okuda T; Mizutani T; Kiyama T; Shimizu Y
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2323-5. PubMed ID: 7944470
[TBL] [Abstract][Full Text] [Related]
34. Neoadjuvant therapy of rectal cancer using oral tegaful-uracil (UFT) plus concomitant radiotherapy--a case report.
Yamaguchi Y; Ohshita A; Hironaka K; Emi M; Kawabuchi Y; Sakatani A; Arihiro K
Hiroshima J Med Sci; 2005 Sep; 54(3):87-91. PubMed ID: 16180702
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial.
Akasu T; Moriya Y; Ohashi Y; Yoshida S; Shirao K; Kodaira S;
Jpn J Clin Oncol; 2006 Apr; 36(4):237-44. PubMed ID: 16675478
[TBL] [Abstract][Full Text] [Related]
36. [Hepatic arterial infusion (HAI) chemotherapy achieved a complete response (CR) for multiple liver metastases of colorectal cancer--two case reports].
Ishibashi K; Yoshimatsu K; Yokomizo H; Umehara A; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1832-4. PubMed ID: 16315955
[TBL] [Abstract][Full Text] [Related]
37. [A case of advanced gastric cancer complicated with liver metastases responding remarkably to combined chemotherapy with 5-fluorouracil and low-dose cisplatin, with UFT and low-dose cisplatin for maintenance on an outpatient basis].
Niiya F; Ikeda S; Nagata S; Iwamoto M; Shirouzu K
Gan To Kagaku Ryoho; 2001 Mar; 28(3):391-4. PubMed ID: 11265411
[TBL] [Abstract][Full Text] [Related]
38. [Long survival in a case of unresectable hepatic metastasis from rectal carcinoma treated with second-look hepatectomy plus pharmacokinetic modulating chemotherapy (PMC)].
Noda M; Kusunoki M; Yanagi H; Yoshikawa R; Yamamura T
Gan To Kagaku Ryoho; 2001 Jan; 28(1):99-103. PubMed ID: 11201390
[TBL] [Abstract][Full Text] [Related]
39. [A case of renal cell carcinoma with lung metastasis and local recurrence effectively treated with nephrectomy and UFT].
Taguchi H; Takaoka K; Matsuda M
Gan To Kagaku Ryoho; 1992 Dec; 19(14):2395-8. PubMed ID: 1463346
[TBL] [Abstract][Full Text] [Related]
40. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
